Ashley Sentell
Acute Care · Detroit, MINPI 1891396800
Payments from drug & device makers
Across 71 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$281
- AstraZeneca$258
- AbbVie$214
- Kestra Medical Technology Services, Inc.$173
- Inari Medical, Inc.$162
- Argenx US, Inc.$149
- plus $631 from 15 others
What the payments were for
- Food & beverage$1,76895%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 17 | $281 |
| AstraZeneca(2 entities) | 4 | $258 |
| AbbVie | 11 | $214 |
| Kestra Medical Technology Services, Inc. | 1 | $173 |
| Inari Medical, Inc. | 1 | $162 |
| Argenx US, Inc. | 7 | $149 |
| Neurocrine Biosciences, Inc. | 4 | $105 |
| Neurelis, Inc. | 4 | $78 |
| Pfizer | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Eisai Inc. | 2 | $48 |
| SK Life Science, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Viatris Specialty LLC | 1 | $24 |
| Sanofi | 1 | $18 |
| Biogen | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,868 in reported general payments places this provider in the 85th percentile of 567 acute care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $9,652 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,128 |
| Levetiracetam | 32 | $760 |
| Donepezil Hcl | 21 | $351 |
| Divalproex Sodium | 12 | $259 |
| Gabapentin | 23 | $235 |
| Atorvastatin Calcium | 51 | $179 |
| Nifedipine ErNifedipine | 13 | $162 |
| Pantoprazole Sodium | 38 | $121 |
| Hydralazine Hcl | 12 | $88 |
| Carvedilol | 17 | $85 |
| Metoprolol Succinate | 13 | $72 |
| Prednisone | 21 | $56 |
| ClopidogrelClopidogrel Bisulfate | 14 | $54 |
| Losartan Potassium | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $9,65217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 567 acute care providers in Michigan.
Other acute care in Detroit
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Eric SimpsonDetroit$6K
- Sarah HudsonDetroit$5K
- Nichole FullerDetroit$4K
- Kristin KreitlerDetroit$4K
- Katie LeonardDetroit$3K
- Rebecca ThompsonDetroit$3K
- Jennifer JilesDetroit$3K
- Lori ChalutDetroit$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.